The importance of diagnosing DLBCL on a molecular level and how it will improve treatment
Hereditary leukemias – clinical implications
Jane E. Churpek
Targeted molecular signatures of DLBCL and upcoming CheckMate 647 trial for PCNSL and PTL
Why do charities need to keep funding research into leukemia and blood cancer in general?
How to manage infections after hematopoietic stem cell transplantation and the issue of resistance